reports
Natural Alternatives International, Inc. Announces New Manufacturing A...
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company (“Juice Plus+”), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sol...
Natural Alternatives International, Inc. Announces Amended and Extende...
Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA (“Wells Fargo”). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairm...
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Res...
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $28.8 million for the third quarter of fiscal year 2025 compared to a net loss of $1.6 million, or $0.27 per diluted share, in the third quarter of the prior fiscal year. Net sales during the three months ended March 31, 2025, ...
Natural Alternatives International and CarnoSyn® Brands Publish Clinic...
Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination CARLSBAD, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands today announced the publication of positive clinical trial results in the journal showing that TriBsyn™ supplementation led to significantly greater bioavailability and efficiency of beta-alanine along with the elimination of paresthesia, a common beta-alanine side effect. ...
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Res...
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results CARLSBAD, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $34.1 million for the second quarter of fiscal year 2025 compared to a net loss of $3.1 million, or $0.52 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December ...
Natural Alternatives International, Inc. Announces 2025 Q1 Results
Natural Alternatives International, Inc. Announces 2025 Q1 Results CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.0 million, or $0.33 per diluted share, on net sales of $33.2 million for the first quarter of fiscal year 2025 compared to a net loss of $0.7 million, or $0.12 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2024, d...
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Cli...
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024 offers a unique platform for companies to present and educate on innovative science in clinical nutrition and metabolism, fostering collaboration with physicians, dietitians, pharmacists, nutritionists, scientists, and nurses. The NAI and CarnoSyn®...
CarnoSyn® Brands stellt TriBsyn™ auf dem 46. ESPEN-Kongress für klinis...
CarnoSyn® Brands stellt TriBsyn™ auf dem 46. ESPEN-Kongress für klinische Ernährung und Stoffwechsel vor CARLSBAD, Kalifornien, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) und CarnoSyn® Brands werden auf dem 46. ESPEN-Kongress für klinische Ernährung und Stoffwechsel vom 7. bis 10. September 2024 in Mailand, Italien, ausstellen. ESPEN 2024 bietet eine einzigartige Plattform für Unternehmen, um innovative wissenschaftliche Erkenntnisse im Bereich der klinischen Ernährung und des Stoffwechsels zu präsentieren und weiterzugeben und die Zusammenarbeit mit ...
CarnoSyn® Brands présente TriBsyn™ au 46e congrès de l’ESPEN sur la nu...
CarnoSyn® Brands présente TriBsyn™ au 46e congrès de l’ESPEN sur la nutrition clinique et le métabolisme CARLSBAD, Californie, 26 août 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) et CarnoSyn® Brands seront présentes au 46e Congrès de l’ESPEN sur la nutrition clinique et le métabolisme qui se tiendra à Milan, en Italie, du 7 au 10 septembre 2024. L’ESPEN 2024 est une plateforme unique qui permet aux entreprises de mettre en avant les innovations scientifiques dans le domaine de la nutrition clinique et du métabolisme, et d’encourager la collaboration avec les mé...
CarnoSyn® Brands presenta TriBsyn™ al 46° Congresso ESPEN sulla nutriz...
CarnoSyn® Brands presenta TriBsyn™ al 46° Congresso ESPEN sulla nutrizione clinica e il metabolismo CARLSBAD, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) e Carnosyn® Brands saranno presenti al 46° congresso ESPEN sulla nutrizione clinica e il metabolismo che si terrà in Italia a Milano dal 7 al 10 settembre 2024. ESPEN 2024 offre alle aziende una piattaforma unica per la presentazione e la formazione sulle innovazioni scientifiche nel campo della nutrizione clinica e del metabolismo, favorendo la collaborazione con medici, dietisti, farmaci...
CarnoSyn® Brands presenteert TriBsyn™ op het 46e ESPEN Congress On Cli...
CarnoSyn® Brands presenteert TriBsyn™ op het 46e ESPEN Congress On Clinical Nutrition & Metabolism CARLSBAD, Californië, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) en CarnoSyn® Brands exposeren op het 46e ESPEN Congress on Clinical Nutrition & Metabolism in Milaan, Italië, van 7 tot 10 september 2024. ESPEN 2024 biedt een uniek platform voor bedrijven om innovatieve wetenschap op het gebied van klinische voeding en metabolisme te presenteren en te delen, waarbij samenwerking met artsen, diëtisten, apothekers, voedingsdeskundigen, wetenschappers en ver...
CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Fre...
CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder” CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology to increase beta-alanine bioavailability and absorption while effectively eliminating beta-alanine related paresthesia. The proprietary TriBsyn™ formulation successfully removes the common paresthesia sensation...
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and ...
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results CARLSBAD, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.6 million, or ($0.27) per diluted share, on net sales of $25.1 million for the third quarter of fiscal year 2024 compared to a net loss of $2.4 million, or ($0.41) per diluted share, in the third quarter of the prior fiscal year. Net sales during the three months ended March...
Natural Alternatives International Scheduled to Reopen U.S. Manufactur...
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs CARLSBAD, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) today announced the expected May 2024 reopening of its state-of-the-art high-volume powder blending and packaging facility located in Carlsbad, CA, following a 7-month closure. NAI temporarily closed the facility in October 2023 due to a significant reduction in customer orders. NAI purchased the Carlsbad facility in August 2021 and spent 2...
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distrib...
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), today announced its expansion in Brazil with Barentz, creating an exclusive distribution channel for CarnoSyn® beta-alanine throughout the entire Brazilian dietary supplements’ market. The new agreement strengthens brand expansion and distribution of a top selling ingredient in sports nutrition—CarnoSyn® beta-alanine—the only scientifical...
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Res...
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $3.1 million, or $0.52 per diluted share, on net sales of $25.2 million for the second quarter of fiscal year 2024 compared to net income of $1.8 million, or $0.31 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, ...
Natural Alternatives International Inc: 1 director sold
A director at Natural Alternatives International Inc sold 13,002 shares at 15.910USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.